Pacira Pharmaceuticals Inc (PCRX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pacira Pharmaceuticals Inc (PCRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9853
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pacira Pharmaceuticals Inc (Pacira) discovers, develops, manufactures and commercializes drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia. Its other products developed under partnerships include DepoCyt (cytarabine liposome injection) for lymphomatous meningitis; and Nocita (bupivacaine liposome injectable suspension) for surgical infiltration in dogs. Its products are used by hospitals and ambulatory surgery centers. The company sells its products through co-promotion agreements and supply agreements with other pharma companies. Pacira is headquartered in Parsippany, New Jersey, the US.

Pacira Pharmaceuticals Inc (PCRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pacira Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
DePuy Synthes Enters into Co-Promotional Agreement with Pacira Pharma for EXPAREL 11
Licensing Agreements 12
Nuance Biotech Enters into Licensing Agreement with Pacira Pharma 12
Pacira Pharma Enters into Licensing Agreement with Aratana Therapeutics 13
Equity Offering 15
Pacira Pharma Completes Public Offering Of Shares For US$117.8 Million 15
Pacira Pharma Completes Underwriters’ Exercise Of Over-Allotment Option For US$67 Million 17
Debt Offering 19
Pacira Pharma Raises USD345 Million in Private Placement of Notes Due 2022 19
Pacira Pharma Completes Private Placement Of Notes Due 2019 For US$120 Million 21
Pacira Pharmaceuticals Inc – Key Competitors 22
Pacira Pharmaceuticals Inc – Key Employees 23
Pacira Pharmaceuticals Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 01, 2018: Pacira Pharmaceuticalsb reports third quarter 2018 financial results 25
Aug 02, 2018: Pacira Pharmaceuticals reports second quarter 2018 financial results 26
May 03, 2018: Pacira Pharmaceuticals Reports First Quarter 2018 Financial Results 27
Feb 28, 2018: Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update 28
Nov 11, 2017: Pacira Pharmaceuticals Reports Third Quarter 2017 Financial Results 30
Mar 01, 2017: Pacira Pharmaceuticals Reports 2016 Financial Results and Provides Business Update 31
Jan 06, 2017: Pacira Pharmaceuticals Reports Preliminary 2016 Revenues of $276.4 Million 32
Corporate Communications 33
Jun 15, 2017: Pacira Pharmaceuticals Appoints Mark I. Froimson, M.D., to Board of Directors 33
May 23, 2017: Pacira Pharmaceuticals Announces Resignation of James Scibetta 34
Other Significant Developments 35
Jul 10, 2018: Pacira Reports Preliminary Net EXPAREL Sales of $80.4 Million for Second Quarter of 2018 35
Jun 13, 2018: MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean Surgery (ERACS) Collaborative to Minimize Opioid Use 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacira Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pacira Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DePuy Synthes Enters into Co-Promotional Agreement with Pacira Pharma for EXPAREL 11
Nuance Biotech Enters into Licensing Agreement with Pacira Pharma 12
Pacira Pharma Enters into Licensing Agreement with Aratana Therapeutics 13
Pacira Pharma Completes Public Offering Of Shares For US$117.8 Million 15
Pacira Pharma Completes Underwriters' Exercise Of Over-Allotment Option For US$67 Million 17
Pacira Pharma Raises USD345 Million in Private Placement of Notes Due 2022 19
Pacira Pharma Completes Private Placement Of Notes Due 2019 For US$120 Million 21
Pacira Pharmaceuticals Inc, Key Competitors 22
Pacira Pharmaceuticals Inc, Key Employees 23
Pacira Pharmaceuticals Inc, Other Locations 24
Pacira Pharmaceuticals Inc, Subsidiaries 24

List of Figures
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pacira Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pacira Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Pacira Pharmaceuticals Inc (PCRX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pan American Silver Corp:企業の戦略・SWOT・財務分析
    Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report Summary Pan American Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CNX Resources Corp (CNX):石油・ガス:M&Aディール及び事業提携情報
    Summary CNX Resources Corporation (CNX Resources), formerly CONSOL Energy Inc., is an independent oil and natural gas company. It carries out the exploration, development, production, gathering, processing and acquisition of natural gas properties in the Appalachian Basin. The company has interests …
  • Famy Care Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Famy Care Ltd (Famy Care) is a healthcare products provider that research, develops and manufactures female reproductive health care products. The company manufactures hormonal and reproductive health care products including famy care. Its hormonal formulation products include combined oral …
  • EnergySolutions, Inc.:企業の戦略・SWOT・財務情報
    EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Laird PLC (LRD):企業の財務・戦略的SWOT分析
    Laird PLC (LRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sojitz Corporation:企業の戦略・SWOT・財務分析
    Sojitz Corporation - Strategy, SWOT and Corporate Finance Report Summary Sojitz Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Majesco
    Majesco - Strategy, SWOT and Corporate Finance Report Summary Majesco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Abaxis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abaxis Inc (Abaxis) is a provider of technology, tools and services for wide range of medical applications for human and veterinary patient-care. The company focuses on development, manufacture, and marketing of portable blood analysis systems. Its portfolio encompasses patented products inc …
  • Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Factory Inc (Otsuka), a subsidiary of Otsuka Holdings Co Ltd is a provider of parenteral and enteral nutrition products. The company’s enteral nutrition products supplies nutrients such as glucose, proteins, fats, electrolytes, and vitamin. It offers over the counter pr …
  • Merrimack Pharmaceuticals Inc (MACK):製薬・医療:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Greenergy International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greenergy International Ltd (GIL) is an energy company that sells petroleum products. The company’s products include petrol, diesel, biodiesel, ultra-low sulphur gasoil, bioethanol, kerosene and ULSG. It offers manufacturing and infrastructure, fuel supply, infrastructure investment, biofuel …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Eiffage SA (FGR):電力:M&Aディール及び事業提携情報
    Summary Eiffage SA (Eiffage) is a construction and concession company. It operates in businesses of energy and infrastructure construction, real estate development, road construction, civil engineering, concessions, and public-private partnerships. The company’s activities include construction, reno …
  • AVI Limited:企業の戦略・SWOT・財務情報
    AVI Limited - Strategy, SWOT and Corporate Finance Report Summary AVI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Harvard Medical School-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers prog …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆